The Maria Sklodowska-Curie National Research Institute of Oncology is a specialized research institute and hospital of the Polish Ministry of Health. Based in Warsaw, it also has regional branches in Gliwice and Kraków.

During the past decade, Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow" are "Melanoma" (4 trials) and "Skin Cancer" (1 trials). Many other conditions were trialed in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow" in a lesser frequency.

Most popular intervention types in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow" are "Biological" (4 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (2 trials), "Placebo" (2 trials), "BMS-986205" (1 trials), "Ipilimumab 1 mg/kg IV" (1 trials) and "Ipilimumab 3 mg/kg IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".